−2.07USD
−551.73 MUSD
91.43 MUSD
51.35 M
About Alvotech
Sector
Industry
CEO
Vilhelm Róbert Wessman
Website
Headquarters
Luxembourg
Employees (FY)
1.03 K
Founded
2018
ISIN
LU2458332611
FIGI
BBG014MBMZY2
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman on August 23, 2021 and is headquartered in Luxembourg.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ALVO is 12.50 USD — it has increased by 2.12% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Alvotech stocks are traded under the ticker ALVO.
Alvotech is going to release the next earnings report on May 21, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Alvotech has a max estimate of 28.00 USD and a min estimate of 14.00 USD.
ALVO earnings for the last quarter are −0.58 USD whereas the estimation was −0.07 USD which accounts for −728.57% surprise. Estimated earnings for the next quarter are 0.04 USD. See more details about Alvotech earnings.
Alvotech revenue for the last quarter amounts to 4.00 M USD despite the estimated figure of 42.00 M USD. In the next quarter revenue is expected to reach 93.00 M USD.
Yes, you can track Alvotech financials in yearly and quarterly reports right on TradingView.
Like other stocks, ALVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alvotech stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 1.03 K employees. See our rating of the largest employees — is Alvotech on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Alvotech EBITDA is −332.60 M USD, and current EBITDA margin is −361.81%. See more stats in Alvotech financial statements.